« Previous
Next »
International Journal of Antimicrobial Agents
Volume 39, Issue 2
, Pages
105-114
, February 2012
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
-
Number of citations found in PubMed from 1999 to the end of 2010 using either ‘Acinetobacter baumannii’ or ‘Acinetobacter baumannii and antibiotic resistance’.
Number of citations found in PubMed from 1999 to the end of 2010 using either ‘Acinetobacter baumannii’ or ‘Acinetobacter baumannii and antibiotic resistance’.
-
Antimicrobial susceptibility testing of a multidrug-resistant, colistin-resistant Acinetobacter baumannii isolate. The disks tested in order from top to bottom and from left to right are as follows: t
Antimicrobial susceptibility testing of a multidrug-resistant, colistin-resistant Acinetobacter baumannii isolate. The disks tested in order from top to bottom and from left to right are as follows: ticarcillin; ceftazidime; piperacillin; piperacillin/tazobactam; imipenem; ticarcillin/clavulanic acid; gentamicin; amikacin; tobramycin; sulfamethoxazole/trimethoprim; fosfomycin; rifampicin; ciprofloxacin; colistin; norfloxacin; nitrofurantoin.
PII: S0924-8579(11)00422-5
doi: 10.1016/j.ijantimicag.2011.10.004
© 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
« Previous
Next »
International Journal of Antimicrobial Agents
Volume 39, Issue 2
, Pages
105-114
, February 2012
